ReviewCancers2022

Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Domenica Lorusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.